glp-1 agonist prediabetes Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP-1-based therapies for type 2

Diabetes Obes Metab 15(1):1527 [DOI] [PMC free article] [PubMed] [Google Scholar] Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

Parkinsons Dis

23 Stay Hydrated: Drinking plenty of fluids, primarily water, throughout the day (but perhaps limiting liquids with meals if nausea is severe) helps with overall digestion and can alleviate constipation

So, when the sugar levels rise after eating, it allows cells to absorb glucose

Cosmetic Abuse: Non-obese individuals are using these drugs for quick, cosmetic weight loss, a trend driven by social media and surrogate advertising from wellness clinics

Tracking food intake can be helpful for patients with obesity, but is contraindicated in patients with an eating disorder